These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models. Stark DT; Bazan NG Mol Neurobiol; 2011 Apr; 43(2):131-8. PubMed ID: 21431475 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells. Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376 [TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Re reduces Aβ production by activating PPARγ to inhibit BACE1 in N2a/APP695 cells. Cao G; Su P; Zhang S; Guo L; Zhang H; Liang Y; Qin C; Zhang W Eur J Pharmacol; 2016 Dec; 793():101-108. PubMed ID: 27840193 [TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Bazan NG Prostaglandins Leukot Essent Fatty Acids; 2009; 81(2-3):205-11. PubMed ID: 19520558 [TBL] [Abstract][Full Text] [Related]
6. NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-β42 by Inhibiting GSK3β Activation in N2a/APP695swe Cells. Dai S; Zhou F; Sun J; Li Y J Alzheimers Dis; 2021; 84(2):869-881. PubMed ID: 34602482 [TBL] [Abstract][Full Text] [Related]
7. The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis. Zhao J; O'Connor T; Vassar R J Neuroinflammation; 2011 Nov; 8():150. PubMed ID: 22047170 [TBL] [Abstract][Full Text] [Related]
8. Tripchlorolide Attenuates β-amyloid Generation via Suppressing PPARγ-Regulated BACE1 Activity in N2a/APP695 Cells. Lin N; Chen LM; Pan XD; Zhu YG; Zhang J; Shi YQ; Chen XC Mol Neurobiol; 2016 Nov; 53(9):6397-6406. PubMed ID: 26582466 [TBL] [Abstract][Full Text] [Related]
9. Different Expression Patterns of Amyloid-β Protein Precursor Secretases in Human and Mouse Hippocampal Neurons: A Potential Contribution to Species Differences in Neuronal Susceptibility to Amyloid-β Pathogenesis. Xu ZQ; Huang H; Chen YL; Gao YY; Xu J; Marshall C; Cai ZY; Xiao M J Alzheimers Dis; 2016; 51(1):179-95. PubMed ID: 26836155 [TBL] [Abstract][Full Text] [Related]
10. Alpha-Linolenic Acid from Perilla frutescens var. japonica Oil Protects Aβ-Induced Cognitive Impairment through Regulation of APP Processing and Aβ Degradation. Lee AY; Lee MH; Lee S; Cho EJ J Agric Food Chem; 2017 Dec; 65(49):10719-10729. PubMed ID: 29092397 [TBL] [Abstract][Full Text] [Related]
11. Role of docosahexaenoic acid in the modulation of glial cells in Alzheimer's disease. Heras-Sandoval D; Pedraza-Chaverri J; Pérez-Rojas JM J Neuroinflammation; 2016 Mar; 13(1):61. PubMed ID: 26965310 [TBL] [Abstract][Full Text] [Related]
12. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. Lukiw WJ; Cui JG; Marcheselli VL; Bodker M; Botkjaer A; Gotlinger K; Serhan CN; Bazan NG J Clin Invest; 2005 Oct; 115(10):2774-83. PubMed ID: 16151530 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Bazan NG Brain Pathol; 2005 Apr; 15(2):159-66. PubMed ID: 15912889 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models. Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727 [TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer's Disease Through Inhibition of BACE1. Wang X; Wang Y; Hu JP; Yu S; Li BK; Cui Y; Ren L; Zhang LD Mol Neurobiol; 2017 May; 54(4):2939-2949. PubMed ID: 27023226 [TBL] [Abstract][Full Text] [Related]
16. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
17. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP. Corbett GT; Gonzalez FJ; Pahan K Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. Bazan NG J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S400-5. PubMed ID: 19018037 [TBL] [Abstract][Full Text] [Related]
19. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related]
20. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. Furukawa K; Sopher BL; Rydel RE; Begley JG; Pham DG; Martin GM; Fox M; Mattson MP J Neurochem; 1996 Nov; 67(5):1882-96. PubMed ID: 8863493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]